Principal Financial Group’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,211
| Closed | -$50.1K | – | 2412 |
|
|
2024
Q1 | $50.1K | Buy |
2,211
+115
| +5% | +$2.61K | ﹤0.01% | 2345 |
|
|
2023
Q4 | $27.2K | Sell |
2,096
-93
| -4% | -$1.21K | ﹤0.01% | 2372 |
|
|
2023
Q3 | $44K | Hold |
2,189
| – | – | ﹤0.01% | 2354 |
|
|
2023
Q2 | $58.8K | Sell |
2,189
-1,068
| -33% | -$28.7K | ﹤0.01% | 2345 |
|
|
2023
Q1 | $190K | Sell |
3,257
-530
| -14% | -$30.9K | ﹤0.01% | 2190 |
|
|
2022
Q4 | $193K | Buy |
3,787
+2,465
| +186% | +$126K | ﹤0.01% | 2205 |
|
|
2022
Q3 | $109K | Sell |
1,322
-31
| -2% | -$2.56K | ﹤0.01% | 2320 |
|
|
2022
Q2 | $91K | Buy |
1,353
+479
| +55% | +$32.2K | ﹤0.01% | 2401 |
|
|
2022
Q1 | $97K | Buy |
874
+63
| +8% | +$6.99K | ﹤0.01% | 2428 |
|
|
2021
Q4 | $78K | Sell |
811
-1,213
| -60% | -$117K | ﹤0.01% | 2458 |
|
|
2021
Q3 | $176K | Buy |
2,024
+108
| +6% | +$9.39K | ﹤0.01% | 2449 |
|
|
2021
Q2 | $297K | Sell |
1,916
-214
| -10% | -$33.2K | ﹤0.01% | 2358 |
|
|
2021
Q1 | $336K | Sell |
2,130
-88
| -4% | -$13.9K | ﹤0.01% | 2246 |
|
|
2020
Q4 | $515K | Buy |
2,218
+651
| +42% | +$151K | ﹤0.01% | 2105 |
|
|
2020
Q3 | $344K | Sell |
1,567
-108
| -6% | -$23.7K | ﹤0.01% | 2103 |
|
|
2020
Q2 | $476K | Buy |
+1,675
| New | +$476K | ﹤0.01% | 1982 |
|
|
2014
Q2 | – | Sell |
-4,267
| Closed | -$1.98M | – | 2269 |
|
|
2014
Q1 | $1.98M | Sell |
4,267
-3,133
| -42% | -$1.45M | ﹤0.01% | 1657 |
|
|
2013
Q4 | $2.54M | Buy |
+7,400
| New | +$2.54M | ﹤0.01% | 1621 |
|